M86.38
Chronic multifocal osteomyelitis, other site
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic multifocal osteomyelitis (CMO) is a rare, long-term condition characterized by inflammation of multiple bones. This disease often affects children and adolescents but can occur at any age. The inflammation in CMO persists over months or years, leading to bone pain and other complications. The ICD-10 code M86.38 specifically refers to cases where this chronic inflammation affects sites other than the commonly impacted bones, making it a distinct category within bone infections.
Causes & Symptoms
Clinical Causes: The exact cause of chronic multifocal osteomyelitis remains unclear. However, several factors are thought to contribute or be associated with the condition: - Autoimmune reactions where the body's immune system mistakenly attacks bone tissue. - Low-grade bacterial infections that are difficult to detect or eradicate. - Genetic predispositions that may increase susceptibility. - Other inflammatory conditions overlapping with osteomyelitis. Despite the term 'osteomyelitis,' which suggests infection, many cases are considered non-infectious or have an unclear infectious component, emphasizing the complex nature of this disease.
Key Symptoms: Patients with chronic multifocal osteomyelitis may experience various symptoms, often developing gradually: - Persistent bone pain, commonly localized but potentially widespread. - Swelling and tenderness over affected bones. - Fever that may be mild or absent. - Fatigue and general malaise. - Limited movement or function in affected limbs or joints. - Possible presence of bone deformities or fractures if the inflammation causes significant bone weakness. Symptoms can vary depending on the bones involved and the severity of the inflammation, often making early diagnosis challenging.
Diagnostic & Treatment
Diagnosis Path: Diagnosing chronic multifocal osteomyelitis involves a combination of clinical assessment, imaging, laboratory tests, and sometimes biopsy: - Medical history and physical examination focused on identifying tenderness and swelling. - Imaging studies such as X-rays, MRI, or CT scans reveal areas of bone inflammation and damage. - Blood tests to detect inflammation markers like ESR and CRP, and assess for infection. - Bone scans can help identify multiple sites of involvement. - Biopsy of affected bone tissue may be performed to rule out other conditions such as infection or tumors and to analyze inflammatory cells. Due to its chronic nature and similarity to other bone disorders, a thorough evaluation is essential for accurate diagnosis.
Treatment Protocols: Managing chronic multifocal osteomyelitis typically involves a multidisciplinary approach, with options tailored to the individual: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain. - Corticosteroids may be prescribed in more severe inflammatory cases. - Immunosuppressive agents if an autoimmune component is suspected. - Antibiotics are used if bacterial infection is confirmed, although their effectiveness can be limited if no infectious agent is identified. - Physical therapy to maintain joint function and muscle strength. - Surgical intervention might be necessary in cases of significant bone destruction or deformity. Long-term management often requires regular follow-up to monitor disease progression and response to treatment, aiming to minimize functional impairment and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M86.38 a billable ICD-10 code?
Yes, M86.38 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M86.38?
Clinical documentation must specify the nature of Chronic multifocal osteomyelitis, other site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
